| Secondary |
| In Vitro Fertilisation |
44.5% |
| Product Used For Unknown Indication |
16.6% |
| Prostate Cancer |
10.9% |
| Ovulation Induction |
8.5% |
| Endometriosis |
3.8% |
| Drug Use For Unknown Indication |
2.8% |
| Bronchitis |
1.9% |
| Assisted Fertilisation |
1.4% |
| Resorption Bone Increased |
1.4% |
| Breast Cancer Female |
0.9% |
| Depression |
0.9% |
| Mineral Supplementation |
0.9% |
| Prophylaxis |
0.9% |
| Prostate Cancer Metastatic |
0.9% |
| Systemic Lupus Erythematosus |
0.9% |
| Agitation |
0.5% |
| Arrhythmia |
0.5% |
| Breast Cancer |
0.5% |
| Folate Deficiency |
0.5% |
| Hormone Therapy |
0.5% |
|
| Breast Cancer |
15.8% |
| Ovarian Hyperstimulation Syndrome |
15.8% |
| Spinal Fracture |
7.9% |
| Ascites |
5.3% |
| Face Oedema |
5.3% |
| Osteopenia |
5.3% |
| Pancreatitis Acute |
5.3% |
| Pelvic Pain |
5.3% |
| Visual Impairment |
5.3% |
| Angioedema |
2.6% |
| Death |
2.6% |
| Decreased Appetite |
2.6% |
| Depressed Mood |
2.6% |
| Gingival Bleeding |
2.6% |
| Hemiplegia |
2.6% |
| Hepatocellular Injury |
2.6% |
| Hyponatraemia |
2.6% |
| Hypotension |
2.6% |
| Infection |
2.6% |
| Liver Function Test Abnormal |
2.6% |
|
| Concomitant |
| Prostate Cancer |
34.5% |
| Drug Use For Unknown Indication |
11.7% |
| Breast Cancer |
8.5% |
| Product Used For Unknown Indication |
8.1% |
| Hypertension |
4.6% |
| Prostate Cancer Metastatic |
4.6% |
| Metastases To Bone |
3.9% |
| Ovulation Induction |
2.9% |
| Hypopituitarism |
2.6% |
| Pain |
2.6% |
| Bone Density Decreased |
2.0% |
| Bone Pain |
2.0% |
| Depression |
2.0% |
| Breast Cancer Female |
1.6% |
| Insomnia |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Asthma |
1.3% |
| Back Pain |
1.3% |
| Blood Pressure Increased |
1.3% |
| Cancer Pain |
1.3% |
|
| Medulloblastoma Recurrent |
9.3% |
| Ischaemic Stroke |
7.4% |
| Osteonecrosis |
7.4% |
| Transaminases Increased |
7.4% |
| Alopecia |
5.6% |
| Dyskinesia |
5.6% |
| Febrile Neutropenia |
5.6% |
| Jaundice |
5.6% |
| Ovarian Hyperstimulation Syndrome |
5.6% |
| Abortion Spontaneous |
3.7% |
| Anaemia |
3.7% |
| Angina Pectoris |
3.7% |
| Bone Disorder |
3.7% |
| Cytolytic Hepatitis |
3.7% |
| Drug Exposure During Pregnancy |
3.7% |
| Faecaloma |
3.7% |
| Hypertension |
3.7% |
| Optic Tract Glioma |
3.7% |
| Osteomyelitis |
3.7% |
| Osteonecrosis Of Jaw |
3.7% |
|
| Interacting |
| Fungal Infection |
50.0% |
| Prostate Cancer Metastatic |
50.0% |
|
| Prostatic Specific Antigen Increased |
100.0% |
|
